Hundreds of clinical trials are rolled out around the world monthly, and many of them are designed to specifically uncover and manage the medical needs of people with sickle cell disease and trait. We keep an updated list of these global studies here, so you don’t have to go searching for them. There might be active study recruitment and enrollment happening at a site near you. Explore the list below to see the different types of studies, and use the navigation options on the left to get as specific as you would like.
This study is a Phase 3, randomized, double-blind, placebo-controlled study of voxelotor in pediatric participants, aged ≥ 2 to < 15 years old, with Sickle Cell Disease.
17 United States sites
5 Nigeria sites
4 Egypt sites
4 Kenya sites
4 United Kingdom sites
3 Italy sites
2 Ghana sites
2 Oman sites
2 Saudi Arabia sites
1 France site
2 Years - 14 Years
SCA
Phase 3
Hydroxyurea Optimization through Precision Study (HOPS) is a prospective, multi-center, randomized trial that will directly compare a novel, individualized dosing strategy of hydroxyurea to standard weight-based dosing for children with SCA.
14 United States sites
6 Months - 21 Years
HbSS, SCA
Phase 3
This is a Phase II study for the use of T-cell replete reduced intensity conditioning (RIC) haploidentical donor allogeneic hematopoietic cell transplantation (HaploHCT) for individuals with high-risk non-malignant diseases who lack a suitable HLA-matched sibling donor.
1 United States site
0 Years - 25 Years
Phase 2
This is a study to collect the outcomes of stem cell transplantation for patients with hematologic diseases other than cancer.
1 United States site
< 55 Years
Not Applicable
